Nanobiotechnology and Nanomedicine Companies
(Links listed alphabetically)
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | All
Showing results 26 - 44 of 44 for companies starting with N:
Nanosens uses nanotechnologies to make smart, portable and inexpensive sensing systems for ultrasensitive and rapid detection of biological and chemical species.
Develops a therapeutic medical device which incorporates a new class of microparticles/nano-shells to selectively destroy solid tumors.
Nanosphere, Inc. is a nanotechnology-based healthcare company, offering proprietary breakthrough technologies that provide a unique and powerful solution to greatly simplify diagnostic testing.
A nanotechnology-based platform for single molecule identification and digital quantification. The NanoString™ system uniquely barcodes individual target molecules, scans them, and delivers a literal inventory of target molecules in the biological sample.
Design, synthesis, and analysis of small molecule organic compounds for the pharmaceutical industry.
NanoTemper Technologies GmbH, a Spin-Off of the Ludwig-Maximilians-University Munich, was founded in May 2008 in order to provide analytical services to pharmaceutical industry, biotechnology and research institues.
Uses nanotechnology to create novel drug delivery systems.
nanoTherics Ltd was formed in August 2007 to exploit a novel gene transfection technology arising from biomedical research at Keele University and the University of Florida. The patented technology uses nanoparticles and magnetic fields to facilitate the delivery of foreign DNA into living cells.
nanoTools provides monoclonal and polyclonal antibody development services and products. Besides providing individually tailored custom solutions, the company develops, manufactures and markets phosphorylation and modification - state specific monoclonal antibodies and other innovative reagents for Signal Transduction and Alzheimer research, high throughput screening (HTS) and proteomics.
An early stage therapeutic drug company, NanoVector Inc. is commercializing a patent pending nanoparticle drug delivery system developed at North Carolina State University. The NanoVector nanoparticle is a plant virus. Central to our technology, this virus, which has evolved over millions of years, has several inherent characteristics essential for a successful nanoparticle delivery system and superior to any designed and engineered by humans.
Nanovex Biotechnologies SL is an innovative technology-based spin-off from the University of Oviedo founded in 2014 that provides a wide range of services and products in the nanobiotechnology field.
A nanobio-pharmaceutical company utilizing nanoscale materials and processes to develop anti-viral drugs against a wide range range of human and animal viruses.
Nanoxis is a biotechnology company with extensive knowledge and experience in membrane protein research. Nanoxis has nanoscale technology solutions based on soft polymer and fluid-state liquid crystalline materials. The company is working on research and development of new nanofabrication technologies in soft polymer and fluid-state liquid crystalline material. These technologies are applicable for production of biochips used in proteomics and genetics and as advanced components for nanofluidics, nanoelectronics and robotics.
The comapny develops nanotechnology and microfluidics for DNA analysis in clinical, forensic, and genomic applications.
Nicast Ltd. develops superior medical devices from electrospun nanofabric for a wide range of clinical applications. Electrospun nanofabric is a biomaterial made of ultra-thin polymer fibers, with properties that mimic those of human tissues and organs.
Nicoya is a nanotechnology company developing novel sensor products. The company's flagship product is OpenSPR - a compact, sensitive, and affordable surface plasmon resonance instrument for molecular analysis.
Novavax is focused on creating novel, highly potent recombinant vaccines produced via cell culture. The company has developed three proprietary technology platforms: Virus-Like Particles, NovasomeŽ paucilamellar vesicles and Micellar Nanoparticles.
NST is a clinical stage molecular imaging and drug development company, focused on the introduction of novel agents (ApoSense - a small molecule 'Interfacial Nanoswitch') based on the identification and targeting of cells undergoing apoptosis.
Develops, manufactures and commercializes medical products based on nanocrystalline silver technology.